Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase Ib/IIa data for a small-molecule BET inhibitor PLX-51107

June 18, 2018

Idorsia starts phase III REACT study with clazosentan

June 18, 2018

Evotec and Sanofi sign agreement in infectious diseases

June 18, 2018

Aminex initiates phase I study of AMXT-1501 dicaprate in advanced solid tumors

June 18, 2018

Celltrion resubmits aBLA for trastuzumab biosimilar CT-P6

June 18, 2018

Nirogacestat receives U.S. orphan drug designation for desmoid tumors

June 18, 2018

Stemline Therapeutics presents data on SL-401 potentially useful in systemic sclerosis

June 18, 2018

STF-1019 protects against experimental enterovirus 71 infection

June 18, 2018

Phase I/II study of BioAtla's BA-3021 in advanced solid tumors begins

June 18, 2018

CytomX initiates first-in-human study of CX-2029 in patients with solid tumors or DLBCL

June 18, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...